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Isolates of the zoonotic pathogen Campylobacter are generally considered to be unable
to metabolize glucose due to lack of key glycolytic enzymes. However, the Entner-
Doudoroff (ED) pathway has been identified in Campylobacter jejuni subsp. doylei and
a few C. coli isolates. A systematic search for ED pathway genes in a wide range of
Campylobacter isolates and in the C. jejuni/coli PubMLST database revealed that 1.7%
of >6,000 genomes encoded a complete ED pathway, including both C. jejuni and
C. coli from diverse clinical, environmental and animal sources. In rich media, glucose
significantly enhanced stationary phase survival of a set of ED-positive C. coli isolates.
Unexpectedly, glucose massively promoted floating biofilm formation in some of these
ED-positive isolates. Metabolic profiling by gas chromatography–mass spectrometry
revealed distinct responses to glucose in a low biofilm strain (CV1257) compared
to a high biofilm strain (B13117), consistent with preferential diversion of hexose-6-
phosphate to polysaccharide in B13117. We conclude that while the ED pathway is
rare amongst Campylobacter isolates causing human disease (the majority of which
would be of agricultural origin), some glucose-utilizing isolates exhibit specific fitness
advantages, including stationary-phase survival and biofilm production, highlighting key
physiological benefits of this pathway in addition to energy conservation.
Keywords: glycolysis, stationary-phase, hexose sugar, polysaccharide, capsule, PubMLST database
INTRODUCTION
The zoonotic pathogen Campylobacter is the cause of human campylobacteriosis, the most
frequently reported foodborne illness in Europe. The symptoms of campylobacteriosis are
gastroenteritis with watery or bloody diarrhea, and the disease is in the majority of cases self-
limiting (Butzler, 2004). The most prominent Campylobacter species causing disease in humans
are C. jejuni and C. coli, which are most frequently associated with the consumption or handling of
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contaminated animal products, especially poultry, but also with
animal or environmental contact (Kaakoush et al., 2015).C. jejuni
is divided into two subspecies:C. jejuni subsp. jejuni, andC. jejuni
subsp. doylei, which are distinguished by the inability of the latter
to reduce nitrate to nitrite (Miller et al., 2007).
Campylobacters are fastidious, microaerophilic, host-adapted
organisms with a metabolic capacity highly tuned to their
biological niche. For C. jejuni, the most widely used carbon
sources are primarily the amino acids aspartate, glutamate,
serine, and proline (Velayudhan et al., 2004; Guccione et al.,
2008; Hofreuter, 2014) as well as certain peptides and organic
acids such as lactate, pyruvate and intermediates of the citric
acid cycle (Wright et al., 2009; Thomas et al., 2011; Hofreuter,
2014). For many years, the general consensus has been that
Campylobacter isolates are unable to catabolise various sugars,
especially glucose, due to the specific lack of glucokinase
(Glk) and phosphofructokinase (PfkA) of the classical Embden-
Meyerhof-Parnas (EMP) glycolysis pathway, while the presence
of the remaining EMP enzymes (Figure 1A) allows the anabolic
generation of hexose phosphate via the reverse reactions of
gluconeogenesis (Parkhill et al., 2000; Velayudhan and Kelly,
2002). However, catabolism of L-fucose, a hexose sugar, was
recently observed in some C. jejuni isolates, which overturned
this view (Muraoka and Zhang, 2011; Stahl et al., 2011). L-fucose
is abundantly present in the mucosal layer of intestinal epithelial
cells, originating from fucosylated mucin glycoproteins, and is
taken up via the fucose permease FucP (Stahl et al., 2011).
The fucP gene was found in 30.3% of 710 C. jejuni isolates
by de Haan et al. (2012) and 57.9% of 266 C. jejuni isolates
by Zautner et al. (2012), indicating that the ability to utilize
L-fucose is quite common but not universal. The genes for
L-fucose catabolism are encoded on a genomic island (Stahl
et al., 2011) and in C. coli isolates, there is evidence that
these genes have been introgressed from C. jejuni (Sheppard
et al., 2013). Significantly, C. jejuni mutants lacking the FucP
permease displayed a competitive disadvantage in colonization
of both chickens and piglets (Stahl et al., 2011). The mechanism
of L-fucose catabolism in Campylobacter has yet to be fully
characterized enzymologically, but seems to proceed by a set
of reactions involving non-phosphorylated intermediates, likely
forming 1 mol pyruvate and 1 mol lactate per mol L-fucose (Stahl
et al., 2011).
Alternative routes to the EMP pathway for the catabolism
of glucose include the oxidative pentose phosphate (PP) and
the Entner-Doudoroff (ED) pathways. The seemingly universal
lack of gluconate-6-phosphate dehydrogenase in campylobacters
means the remaining PP enzymes form a purely anabolic
pathway. However, the ED pathway genes and a possible glucose
transporter gene were first observed in the sequence of C. jejuni
subsp. doylei 269.97 (Figure 1B) and proposed as a theoretical
way of glucose utilization in this isolate by Miller (2008).
Importantly, whereas the EMP pathway produces 2 mol ATP and
2 mol NADH per mol glucose, the ED pathway produces 1 mol
each of ATP, NADH, and NADPH per mol glucose (Flamholz
et al., 2013). Mechanistically, the ED pathway is somewhat similar
to the EMP pathway in that it involves initial activation of the
C6 sugar by phosphorylation and a subsequent aldol cleavage
to give two C3 intermediates (Conway, 1992), but unlike the
EMP pathway the ED aldolase reaction yields one mol of triose
phosphate and one mol of pyruvate directly. The key enzymes are
6-phosphogluconate dehydratase (Edd) and 2-keto-3-deoxy-6-
phosphogluconate aldolase (Eda) (Conway, 1992; Flamholz et al.,
2013). Edd catalyzes the dehydration of gluconate-6P to 2-keto-3-
deoxy-gluconate-6P, while Eda catalyzes the aldol cleavage of this
compound to pyruvate and glyceraldehyde-3P. In addition, the
ED pathway requires a glucokinase (Glk), a glucose-6-phosphate
dehydrogenase (Zwf) and a 6-phosphogluconolactonase (Pgl)
for conversion of glucose to gluconate-6P, the substrate of Edd
(Figure 1A).
There are a number of variations of the ED pathway in
different groups of bacteria (Conway, 1992). For example, in
Zymomonas mobilis (a common cause of spoilage of fermented
beverages) the pathway is constitutive, effectively linear and
is the sole mechanism of converting glucose to pyruvate. In
enteric bacteria like Escherichia coli, the ED pathway enzymes
are inducible and serve primarily in gluconate catabolism,
with glucose itself being catabolized preferentially by EMP-
mediated glycolysis (Conway, 1992). Gluconate is present in
the intestine; interestingly, although campylobacters cannot
catabolise gluconate (Pajaniappan et al., 2008; Vorwerk et al.,
2015), C. jejuni has been shown to use it as an electron
donor for respiration via a periplasmic gluconate dehydrogenase
(Pajaniappan et al., 2008). A third “cyclic” ED pathway variation
is found in Pseudomonas spp. that, like campylobacters, lack
6-phosphofructokinase. Here, there is evidence from labeling
studies (Nikel et al., 2015) that a portion of the triose-phosphate
formed by the Eda aldolase reaction is cycled back to hexose
phosphate via the gluconeogenic reactions of the EMP pathway
(see Figure 1A); this has recently been dubbed the “EDEMP”
pathway (Nikel et al., 2015). From genomic studies it seems
that the ED pathway (and its variants) is much more common
in facultative and obligate aerobes, while anaerobes rely on the
EMP pathway (Flamholz et al., 2013). One attractive hypothesis
is that both triose-phosphate and pyruvate can be produced with
far fewer enzymes by the ED pathway compared to the EMP
pathway, which can be viewed as a trade-off with the reduced
ATP yield (Flamholz et al., 2013). This may be of particular
importance for glucose utilization in small genome, host adapted
pathogens.
Recently, in an elegant and detailed study using mutagenesis,
13C-isotopolog analysis and enzyme studies, Vorwerk et al.
(2015) discovered that a functional ED pathway exists in
certain C. coli isolates, which enables this pathogen to utilize
glucose as a growth substrate. Moreover, the pathway (like that
for L-fucose) was found to be encoded on a genomic island
or ‘plasticity region,’ designated the glc locus, that could be
transferred between ED-positive and ED-negative isolates by
natural transformation, suggesting acquisition of the glc-enoded
ED pathway could contribute to the expansion of metabolic
diversity in campylobacters (Vorwerk et al., 2015). However,
knowledge of the actual distribution of the ED pathway genes in
isolates from a range of different sources is lacking and it is thus
not clear what the role or importance of glucose utilization is in
the context of the known genomic diversity of campylobacters.
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FIGURE 1 | The Entner-Doudoroff pathway in Campylobacter isolates. (A) Scheme of the ED pathway to illustrate how the reactions effectively bypass the
lack of phosphofructokinase, which prevents glycolysis by the EMP pathway in Campylobacter, but can also allow cycling of triose-phosphate back to hexose
phosphate. The key enzymes 6-phosphogluconate dehydratase (Edd) and 2-keto-3-deoxy-6-phosphogluconate aldolase (Eda) catalyze the dehydration of
(Continued)
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FIGURE 1 | Continued
phosphate back to hexose gluconate-6P to 2-keto-3-deoxy-gluconate-6P and the further aldol cleavage to pyruvate and glyceraldehyde-3P, respectively. In
addition, the ED pathway requires a glucokinase (Glk), a glucose-6-phosphate dehydrogenase (Zwf) and a 6-phosphogluconolactonase (Pgl) for conversion of
glucose to gluconate-6P, the substrate of Edd. Two phosphoglucose isomerases (Pgi1 and Pgi2) catalyze the same reaction. ED pathway specific enzymes are boxed;
Pgi2 is encoded at the glc locus (Vorwerk et al., 2015) and may be required to feed fructose-6-phosphate into the reductive pentose phosphate pathway (RPPP).
(B) Organization of the glc locus encoding the ED pathway in Campylobacter jejuni subsp. doylei 269.97. The locus is situated between the 16S and 23S ribosomal
rRNA genes and contains the genes pgi2, glk, pgl, zwf, edd and eda in addition to the glucose transporter glcP. (C) Screen for napA, napB, edd, and eda genes
in Campylobacter isolates. Top panels show PCR fragments of the nitrate reductase genes napA (internal fragment) and napB (flanking fragment) used to discriminate
C. jejuni subsp. doylei (Cjd) from C. jejuni subsp. jejuni (Cjj) and C. coli (Cc). Cjj and Cc encode both napA and napB and thus the ability to reduce nitrate. In contrast,
Cjd has deletions in napA and sometimes also napB, thus leaving this subsp. unable to reduce nitrate (Miller et al., 2007). None of the Cjd isolates showed
amplicons with the napA internal primers. The napB diversity of Cjd is illustrated by the variable fragment lengths amplified with the napB flanking primers, as described
by Miller et al. (2007). Middle panels show amplified ca. 810 bp fragments of the edd gene from Cjd 269.97, Cjd CCUG 18265 and Cc B13117. Bottom
panels show amplified ca. 600 bp fragments of the eda gene from Cjd 269.97, Cjd CCUG 18265 Cjd CCUG 24567, and Cjd CCUG 26155. Lanes M contain
molecular size markers.
In this study we show by systematic genomic analyses
that the ED pathway genes are present in only 1.7% of
>6,000 genomes encompassing a diverse range of isolates
of both of the major pathogenic species of Campylobacter
(C. jejuni and C. coli). However, we demonstrate that the ED
pathway provides a significant benefit for C. coli in prolonged
growth experiments in rich media, where ED-positive isolates
display significantly extended stationary-phase survival in the
presence of glucose. Interestingly, metabolic profiling revealed
that individual ED-positive isolates can respond very differently
to glucose, correlating with glucose-stimulated formation of a
pellicle or floating biofilm in some isolates. We conclude that
although the ability to utilize glucose is generally uncommon
in Campylobacter, it is found in a more diverse range of
isolates than previously suspected and we provide evidence that
the ED pathway, in addition to a purely catabolic role, also
confers distinct physiological advantages in survival and biofilm
formation in some isolates.
MATERIALS AND METHODS
Bacterial Isolates and Growth Conditions
The origins and details of the Campylobacter isolates used
in this study are given in Supplementary Table S1. Isolates
were routinely cultivated on Blood Agar Base No. 2 (Oxoid)
supplemented with 5% (v/v) bovine blood and incubated at 37◦C
under microaerobic conditions (6% v/v CO2; 6% v/v O2; 3.4%
v/v H2, and 80.6% v/v N2). Growth experiments were carried out
with and without 100 mM glucose supplementation in Tryptic
Soy Broth (TSB) without Dextrose (Becton Dickinson and Co.)
or in modified MCLMAN minimal media (Alazzam et al., 2011)
without lactate and with 2 mM aspartate. Viable cell counts
were determined by plating serial dilutions in phosphate buffered
saline on Blood Agar Base No. 2 (Oxoid) and incubating under
the conditions described above.
PCR Screen for ED Pathway Genes
Campylobacter isolates (Supplementary Table S1) were
screened for the ED pathway genes by PCR using
oligonucleotides for edd (5′-ATAAATTGGGATGATTTTG
and 5′-TCTAAACCCTGCAAAAAGCTC giving a ca 810 bp
fragment) and eda (5′-GGAGAAAAAATGCAAACAA and
5′-TCTAAACCCTGCAAAAAGCTC giving a ca 600 bp
fragment). Oligonucleotides for napA and napB (periplasmic
nitrate reductase) were used in multiplex PCR reactions to
discriminate C. jejuni subsp. doylei from C. jejuni subsp. jejuni
and C. coli using the nap mpx2 primer set as described by Miller
et al. (2007), which consists of internal napA primers and napB
flanking primers. Chromosomal DNA was extracted with the
DNeasy Blood and Tissue kit (Qiagen) and the DreamTaq Green
DNA polymerase (Thermo Fisher) was applied for the PCR
amplifications.
Whole Genome Sequencing and
Assembly
Genomic DNA was extracted from bacterial cultures of CCUG
18265, CCUG 24567, CCUG 26155, B13117, and CV1257
using the Wizard Genomic DNA Purification Kit (Promega,
Southampton, UK). Whole-genome sequencing (WGS) was
carried out at the Wellcome Trust Sanger Institute, UK. Illumina
multiplex libraries were generated by acoustic shearing, after
which up to 96 libraries were pooled in equimolar ratios and
sequenced on a single flow cell lane on the Illumina HiSeq
platform, producing 100 bp paired-end reads, as previously
described (Cody et al., 2013). The short-read data were submitted
to an automated pipeline (Jolley and Maiden, 2010; Bratcher et al.,
2014), which integrates VELVET version 1.2.01 (Zerbino and
Birney, 2008) and VELVETOPTIMISER version 2.2.0 (Zerbino,
2010) for de novo assembly. Draft genomes were then uploaded to
the C. jejuni/coli PubMLST database (Supplementary Table S2).
Genome Annotation and In silico
Identification of ED-Positive Isolates
Loci corresponding to glcP (CAMP2017), pgi2 (CAMP2018),
glk (CAMP2019), pgl (CAMP2020), zwf (CAMP2021), edd
(CAMP2022), and eda (CAMP2023) were added to the
C. jejuni/coli PubMLST database (PubMLST locus names shown
in parentheses), using sequences from C. jejuni subsp. doylei
269.97 (GenBank accession number NC_009707) to seed the
database. The glc loci, in addition to MLST, rMLST, and
C. jejuni/coli core genome scheme loci, were annotated in the
study genomes using the Bacterial Isolate Genome Sequence
Database (BIGSDB) ‘autotagger’ functionality implemented in
PubMLST (Jolley and Maiden, 2010). The autotagger uses BLAST
to search a genome for sequences similar to loci defined in the
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database. For sequences with≥98% identity to existing alleles, the
autotagger defined the position of the locus and assigned a unique
allele number in order of discovery (Jolley and Maiden, 2010).
Sequences with <98% identity to existing alleles were curated
manually. The same approach was used to annotate components
of the glc locus in publicly available genomes present in the
C. jejuni/coli PubMLST database. A summary of the allelic data
for MLST and glc loci from all ED-positive isolates was generated
using the BIGSDB data export plugin. ED types were generated as
for MLST sequence types: unique combinations of alleles across
the glc loci, taken in gene order from glcP to eda, were assigned
arbitrary numbers in order of discovery.
Genomic Analyses
Genomic analyses were carried out using the hierarchical gene-
by-gene approach implemented in BIGSDB, which allows users
to compare isolates at varying numbers of loci, depending on
the level of resolution required (Jolley and Maiden, 2010; Maiden
et al., 2013). Species assignments of all ED-positive isolates, and
C. coli clade membership, were confirmed using rMLST (Jolley
et al., 2012; Jansen van Rensburg et al., 2016). A maximum
likelihood tree based on concatenated nucleotide sequences of the
glc genes was reconstructed in MEGA version 6.06 (Tamura et al.,
2013) using the General Time Reversible model with gamma-
distributed rates with 500 bootstrap replicates. The resulting
phylogenetic tree was annotated online using the Interactive
Tree of Life version 3 (Letunic and Bork, 2016). Relationships
among ED-positive isolates were established based on wgMLST
analyses carried out using the GENOME COMPARATOR module
implemented in the C. jejuni/coli PubMLST database (Jolley
and Maiden, 2010). Following the exclusion of genomes in
which ≥1% of the 1,343 C. jejuni/coli core genome scheme
loci were incomplete (i.e., at the ends of contigs), relationships
among C. jejuni and C. coli isolates were evaluated using
wgMLST. Isolates were compared to the reference genomes of
C. jejuni NCTC11168 (GenBank accession number AL111168)
(Parkhill et al., 2000; Gundogdu et al., 2007) or C. coli 15-
537360 (CP006702) (Pearson et al., 2013), using the default
GENOME COMPARATOR settings. Distance matrices generated by
GENOME COMPARATOR were visualized as networks using the
NeighborNet algorithm (Bryant and Moulton, 2004) in SplitsTree
version 4.13.1 (Huson and Bryant, 2006). Further analyses were
carried out to compare the isolates B13117 and CV1257. The
genome sequences of these isolates were annotated using Prokka
version 1.0 (Seemann, 2014). The number of shared and unique
coding sequences was estimated with Roary version 3.6.0 (Page
et al., 2015) using the default settings. The capsule gene regions
of these isolates were compared using ACT (Carver et al., 2005).
Phenotype Microarray Assays
BIOLOGTM phenotype microarrays were set up according to
the manufacturer’s description for C. jejuni. Briefly, individual
isolates were cultivated overnight on Blood Agar Base No.
2 supplemented with 5% v/v bovine blood at 37◦C in a
microaerobic atmosphere. Cells were harvested from plates
with 1.2x IF-0a solution (Biolog, Inc.), gently resuspended and
adjusted to an optical density (600 nm) of 0.8. For each strain,
8 ml cell suspension was mixed with 12 ml 1.2x IF-0a (Biolog,
Inc.), 0.24 ml Dye mix D (Biolog, Inc.), 6 mg ml−1 BSA,
1.26 mg ml−1 NaHCO3, and 1.76 ml water. This mixture
(0.1 ml) was added to the wells of PM1 phenotype microarray
plates (Biolog), and the initial absorbance at 590 nm was
read in an ELISA plate reader. Plates were incubated at 37◦C
in a microaerobic atmosphere and the absorbance read again
following 24 and 48 h of incubation.
Biomass Dry-Weight Determination
Following 7 days of incubation at 37◦C in a microaerobic
atmosphere, C. coli cultures in glucose-free TSB with and without
supplementation with 100 mM glucose were homogenized
carefully by pipetting. Biomass was harvested from 5 ml culture
by centrifugation and the pellets incubated overnight at 50◦C for
evaporation of water content. The dry weight of biomass was
determined as the mean of four replicates.
Metabolite Analysis by Gas
Chromatography–Mass Spectrometry
Campylobacter coli B13117 and CV1257 were cultivated at
37◦C under microaerobic conditions in TSB with and without
supplementation with 100 mM glucose. Three independent
cultures for each strain and condition were grown; following
24 h of incubation, cells were harvested from 5 ml culture
by centrifugation for 1 min at 8,000 × g at 0◦C. The
supernatants were filter sterilized (0.2 µm pore size) and stored
at −20◦C until analysis. A procedure based on the methyl
chloroformate derivatisation protocol described by Smart et al.
(2010) was used for the analysis of mixtures containing known
metabolites with and without complexation. All samples were
analyzed in a randomized order. The system was controlled by
ChemStation (Agilent technologies). Raw data was converted to
netCDF format using Chemstation (Agilent), before the data was
imported into Matlab R2014b (Mathworks, Inc., Natick, MA,
USA) and processed using PARAFAC2 (Bro et al., 1999; Kiers
et al., 1999) to obtain relative concentrations for each peak.
PARAFAC2 was applied using in-house algorithms.
RESULTS
Carriage of the ED Pathway Genes Does
Not Correlate with Ability to Grow in
Blood
The key ED pathway genes were originally identified in the
genome sequence of the human blood isolate C. jejuni subsp.
doylei 269.97 (Miller, 2008). Since C. jejuni subsp. doylei is
overrepresented in human cases of Campylobacter bacteremia
(Lastovica, 2006; Parker et al., 2007) and given the millimolar
concentrations of glucose in blood, we initially wanted to test the
hypothesis that the ED pathway might be specifically associated
with the growth or survival of Campylobacter found in blood.
Therefore, a range of Campylobacter isolates was screened for
the ED pathway using PCR amplification of the key genes
(Figure 1C). This screen included five clinical isolates of C. jejuni
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subsp. doylei (CCUG 18265, CCUG 24567, CCUG 26152, CCUG
26155, CCUG 36506), a C. coli bacteremia isolate (B13117),
an in-house C. coli isolate of unknown origin (CV1257) and
10 C. jejuni subsp. jejuni bacteremia isolates (S38543, B10540,
B345, B15426, B130, B17648, B19978, B3-11, B5682, B10053)
(see Supplementary Table S1 for details). The screen revealed
the presence of 6-phosphogluconate dehydratase (edd) and/or
aldolase (eda) genes, encoding the key ED pathway enzymes,
in three out of five clinical C. jejuni subsp. doylei isolates
(CCUG24567, CCUG18265, CCUG26155), both C. coli isolates
(B13117, CV1257), but not in any of the examinedC. jejuni subsp.
jejuni bacteremia isolates (Figure 1C and results not shown).
These findings therefore do not support an association between
blood culture isolates and the key genes of the glc locus. Analysis
of WGS data for CCUG 24567, CCUG 18265, CCUG 26155,
B13117, and CV1257 (Supplementary Table S2) confirmed that
all isolates carried the complete glc locus.
In silico Identification of ED-Positive
Campylobacter Isolates
The availability of assembled WGS data in the C. jejuni/coli
PubMLST database facilitated large-scale in silico searches for
additional ED-positive isolates. We found that 113 out of 6,184
isolates with genomic data contained one or more components of
the glc locus. The glc locus did not assemble into a single contig in
six isolates, all of which corresponded to draft genomes. Breaks
occurred within the genes of interest, likely due to misassembly
or lack of coverage; these isolates were excluded from further
analyses. The complete glc locus was present on a single contig
in the remaining 107 isolates (1.7% of the total) (Supplementary
Table S2), which were collected in the UK (n = 76), Finland
(n= 30), and the USA (n= 1).
Based on ribosomal multilocus sequence typing (rMLST)
(Jolley et al., 2012), 70 and 37 isolates corresponded to C. jejuni
and C. coli, respectively. At the population level, C. coli isolates
segregate into three groups known as clades 1, 2, and 3 (Sheppard
et al., 2008; Sheppard et al., 2010); the ED-positive C. coli isolates
were all assigned to clade 1, except OXC7653, which belonged
to clade 3. With respect to sources of isolation, C. jejuni isolates
were predominantly from rats (51.4%) and wild birds (42.9%). In
contrast, human disease samples accounted for 43.2% of C. coli
isolates, while the remainder were from a diverse range of sources,
including animals, food, and the environment (Table 1).
Allelic Diversity of the glc Locus
The seven genes comprising the glc locus were annotated as
described in Experimental Procedures, using the autotagger
functionality implemented in PubMLST (Jolley and Maiden,
2010). Unique alleles identified for each gene were assigned
arbitrary numbers in order of discovery. Between 12 (eda) and
22 (pgi2) alleles per glc locus gene were present among C. jejuni
subsp. doylei 269.97, the five ED-positive isolates sequenced for
this study, and those from the C. jejuni/coli PubMLST database
(Table 2). Gene lengths ranged from 624 bp (eda) to 1803 bp
(edd), and allele lengths were variable for all loci except edd,
eda, and pgl (Table 2). Unique combinations of glc locus alleles,
TABLE 1 | Sources of ED-positive isolates from the Campylobacter
jejuni/coli PubMLST database.
Source n (%)
C. jejuni C. coli
Chicken 0 (0) 1 (2.7)
Environmental waters 0 (0) 4 (10.8)
Farm environment 2 (2.9) 1 (2.7)
Human disease 0 (0) 16 (43.2)
Other food 0 (0) 2 (5.4)
Pig 0 (0) 5 (13.5)
Rat 36 (51.4) 3 (8.1)
Soil 0 (0) 3 (8.1)
Unknown 2 (2.9) 2 (5.4)
Wild bird 30 (42.9) 0 (0)
TABLE 2 | Allelic diversity of components of the glc locus among 113
ED-positive Campylobacter isolates.
Gene Number of alleles Length of seed
sequence
Range of
allele lengths
glcP 20 1212 1200–1215
pgi2 22 1644 1644–1688
glk 19 999 999–1014
pgl 15 681 681
zwf 13 1401 1398–1401
edd 20 1803 1803
eda 12 624 624
taken in gene order from glcP to eda, were summarized as
ED types, which were assigned arbitrary numbers in order of
discovery. Overall, 46 ED types were identified, all of which were
species-specific: 36 were present in C. jejuni and 10 in C. coli.
C. jejuni isolates were evenly distributed across ED types, with
the exception of 18 closely related rat isolates that had been
isolated from four different farms between 2011 and 2012 and
which all carried ED type 2 (ED allelic profile 3-4-4-5-4-5-5).
Interestingly, these findings with C. jejuni contrasted with a more
limited allelic diversity observed for C. coli isolates, amongst
which ED type 1 (3-5-7-9-5-9-9) was predominant, accounting
for 27/37 (73%) of PubMLST isolates and CV1257. Phylogenetic
analysis of concatenated glc gene sequences indicated that ED
types segregated into three groups, with C. jejuni ED types
occurring in all three (Figure 2). There was little diversity among
C. jejuni sequences from groups I and III, which primarily
corresponded to isolates obtained from wild birds or rats,
respectively. Sequences belonging to group II were more diverse
and included the known C. jejuni subsp. doylei isolates. With the
exception of clade 3 isolate OXC7653, C. coli sequences were only
found in group III and were highly homogeneous (Figure 2).
Genomic Analyses of ED-Positive
Isolates
Relationships among ED-positive isolates were examined using
whole-genome multilocus sequence typing (wgMLST). Seven
isolates were excluded from these analyses as 1–16.5% of
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FIGURE 2 | Phylogenetic relationships among Campylobacter glc loci.
Maximum likelihood tree based on concatenated nucleotide sequences of
genes comprising the glc locus, encoding the Entner-Doudoroff pathway, from
113 Campylobacter isolates. Colored strips adjacent to the phylogeny
indicate species and source as shown in the inset legends. Known C. jejuni
subsp. doylei isolates are indicated with filled circles. All C. coli isolates were
assigned to C. coli clade 1, with the exception of a single clade 3 isolate,
which is marked with a star. Isolates included in experiments carried out in this
study are labeled. Roman numerals indicate groups of glc sequences referred
to in the text. For major nodes, bootstrap values generated from 500
replicates are shown as percentages. The scale bar represents the number of
nucleotide substitutions per site.
loci belonging to the C. jejuni/coli core genome scheme were
incomplete (i.e., at ends of contigs). With respect to C. jejuni,
wild bird, rat, and known C. jejuni subsp. doylei isolates
largely occupied distinct parts of the network that correlated
with membership of the three ED nucleotide sequence groups
(Figures 2 and 3). Members of these groups were genetically
diverse and were separated by an average of 1,294 loci, with the
exception of small clusters of closely related isolates, particularly
among those obtained from farm-associated rats (Figure 3A).
Isolates belonging to these clusters were typically separated by
fewer than 100 loci and the majority carried ED type 2. Although
C. coli isolates were also genetically diverse, they were separated
by shorter distances, averaging 973 loci (Figure 3B). While the
majority carried ED type 1, these isolates did not group by source
or ED type.
Glucose Supports Growth of
Campylobacter Isolates Harboring the
ED Pathway
The presence of the ED pathway genes within the subset
of Campylobacter isolates studied here indicates that these
isolates should be able to utilize glucose. To confirm this, a
BiologTM phenotypic microarray was initially used to examine
the potential metabolism of various carbohydrates by the ED-
positive isolates C. coli B13117, C. coli CV1257 and C. jejuni
subsp. doylei 269.97 in comparison to the widely used lab strain
C. jejuni NCTC11168, which does not carry the ED pathway.
With the BiologTM system, substrate uptake and metabolism is
detected as stimulation of bacterial respiration and quantitated
colorimetrically via tetrazolium dye reduction (Bochner et al.,
2001). This revealed a correlation between the presence of the
ED pathway and metabolism of glucose, as glucose was seen to
stimulate respiration of the ED-positive C. jejuni subsp. doylei
269.97, C. coli B13117 and C. coli CV1257, while no signal was
observed for C. jejuni NCTC11168. In contrast, L-fucose was
seen to stimulate respiration of all four isolates regardless of the
presence of the ED pathway (Supplementary Figure S1).
To investigate if glucose is able to support growth of C. coli
isolates carrying the ED pathway, the growth of four ED-
positive C. coli isolates representing three different sequence
types (B13117, CV1257, Dg172, and Dg349) was examined
in comparison to an ED-negative strain (OXC6725; PubMLST
id 18282). Of these isolates, CV1257, Dg172, and Dg349
all had ED type 1 (the same as in the isolates used by
Vorwerk et al., 2015), while B13117 carried ED type 45,
which only differed by a single synonymous substitution in
pgi2 (471: T- > C). The isolates were grown in minimal
media (MCLMAN) without and with glucose supplementation
as the main carbon source; a low concentration of L-aspartate
(2 mM) was included as a nitrogen source as this was
found to greatly aid growth. Following overnight incubation
at 37◦C under microaerobic conditions, the viable cell count
of each of the ED-positive isolates had increased significantly
with glucose (by ∼3 logs), while no such increase in cell
density was seen for either the ED-negative strain or any
of the cultures without glucose supplementation (Figure 4).
These data show a clear correlation between possession of
the ED pathway in these C. coli isolates and their growth on
glucose.
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FIGURE 3 | Relationships among ED-positive Campylobacter isolates. NeighborNet graphs were generated based on whole-genome multilocus sequence
typing (wgMLST) comparisons of 68 C. jejuni (A) and 38 C. coli (B) isolates, using NCTC11168 and 15-537360 (black squares), respectively, as reference genomes.
ED allele types are shown as numbers adjacent to each isolate. Isolates included in experiments carried out in this study are labeled in full with the ED type in
parentheses. Dashed lines and Roman numerals indicate groups of isolates with related ED types referred to in the text. The color of the filled circles indicates the
source of each isolate as shown in the key (inset). All C. coli were assigned to C. coli clade 1 except for a single clade 3 isolate, which is marked with a star.
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FIGURE 4 | Glucose stimulates growth of ED-positive but not ED-negative C. coli isolates. Four ED-positive C. coli isolates (B13117, CV1257, Dg172, and
Dg349) and an ED-negative control C. coli strain (OXC6725) were inoculated into modified MCLMAN minimal media either without or with glucose supplementation.
Cultures were incubated for 20 h at 37◦C under microaerobic conditions and viable cell numbers measured by plate counts. White bars, colony forming units (CFU)
ml−1 of inoculum at time 0. Light gray bars, final CFU ml−1 in modified MCLMAN without glucose. Black bars, final CFU ml−1 in modified MCLMAN supplemented
with 100 mM glucose. The bars show the mean and the error bars show the standard deviations of three independent cultures. Statistical significance is indicated by
(∗∗p < 0.01) or (∗∗∗p < 0.001) as determined by Student’s t-test.
Extended Stationary Phase Survival and
Strain-Specific Biofilm Production with
Glucose
In order to examine the physiological impact of glucose
metabolism by C. coli, the growth of ED-positive isolates was
further examined in the rich medium tryptic soy broth (TSB)
without and with glucose supplementation. Here, a range of
carbon sources (mainly amino-acids and peptides), are available
in addition to the added glucose. At 37◦C in a microaerobic
atmosphere, the exponential growth rates of B13117 and CV1257
were seen to be unaffected by the availability of glucose
(Supplementary Figure S2). After 12 h of incubation, however, the
viability of the un-supplemented cultures declined significantly.
In contrast, viable cell numbers were sustained or slightly
increased in the glucose-supplemented cultures (Supplementary
Figure S2), hence, suggesting glucose might support extended
viability and stationary survival of these ED-positive isolates, at
least up to 24 h.
Extending the growth experiments with prolonged incubation
time over several days and including four ED-positive C. coli
isolates (B13117, CV1257, Dg172, and Dg349) and an ED-
negative control C. coli strain (OXC7218; PubMLST id 22709),
revealed that glucose did indeed support significant extended
survival of the ED-positive isolates (Figure 5). When cultivated
with glucose at 37◦C in a microaerobic atmosphere, the ED-
positive isolates B13117, CV1257, Dg172, and Dg349 displayed
at least 10 times higher viable cell numbers after 4 and 7 days
as compared to cultures without glucose, while no such effect
of glucose could be seen with the ED-negative strain OXC7218
(Figure 5). These data show a major impact of glucose on the
late stationary phase survival of ED-positive C. coli isolates under
otherwise nutrient rich conditions.
In the extended incubation experiments, it was observed
that glucose stimulated biofilm formation by some ED-positive
isolates of C. coli. Substantial floating biofilm (flocs or a pellicle),
i.e., biofilm unattached to a surface, was observed in the glucose-
supplemented late stationary cultures of B13117 and Dg349,
and this aggregation was in fact so viscous that it was hardly
dispersible by simple pipetting (Figure 6A). However, extensive
biofilm formation was not observed in either the glucose-free
cultures of B13117 and Dg349 or any of the late stationary
cultures of the two other ED-positive isolates CV1257 and Dg172
in the presence of glucose. The ED-negative strain OXC7218
displayed a low level of aggregation regardless of the glucose
availability (Figure 6A). Note that the biofilm produced by C. coli
B13117 and Dg349 is floating, i.e., unattached to a solid surface,
and therefore it was not possible to quantify using traditional dye
staining assays for staining of attached biofilms. Consequently,
the contribution of the biofilm to the total cell biomass was
quantified using the dry weight of culture aliquots following
7 days of incubation with and without glucose (Figure 6B). As
expected, this showed a significant increase in the biomass of
all the ED-positive isolates upon glucose supplementation, while
the biomass of the ED-negative strain was unaltered regardless
of glucose availability. However, the biomass of B13117 and
Dg349 grown with glucose was clearly much greater than that of
CV1257 and Dg172 with glucose (Figure 6B, arrows), which is in
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FIGURE 5 | Extended stationary phase survival with glucose. Viable cell numbers of ED-positive C. coli isolates (B13117, CV1257, Dg172, and Dg349) and an
ED-negative control C. coli strain (OXC7218) were determined in TSB with or without supplementation with 100 mM glucose. Cultures were incubated for 7 days at
37◦C in microaerobic conditions and the viability determined by enumerating CFU at various time intervals. Results are mean and standard deviations of three
independent cultures. The error bars are too small to be seen in some cases. (A) C. coli B13117; (B) C. coli CV1257; (C) C. coli Dg172; (D) C. coli Dg349;
(E) C. coli OXC7218 (ED-negative control). Open circles and dashed line, cell numbers without glucose; filled circles and solid line, cell numbers with glucose. The
statistical significance of the difference between the control without glucose and with added glucose at 7 days was tested by Student’s t-test, as indicated by
(∗∗∗p < 0.001) or NS (not significant).
Frontiers in Microbiology | www.frontiersin.org 10 November 2016 | Volume 7 | Article 1877
fmicb-07-01877 November 18, 2016 Time: 18:12 # 11
Vegge et al. Glucose Metabolism in Campylobacter Isolates
FIGURE 6 | Glucose stimulates production of floating biofilm that increases cell biomass. (A) The isolates of C. coli shown were cultivated for 4 days at
37◦C under microaerobic conditions in glucose-free TSB with and without supplementation with 100 mM glucose. The glucose-supplemented cultures of B13117
(ED+) and Dg349 (ED+) formed extensive floating biofilm (flocs; arrowed). CV1257 (ED+) and Dg172 (ED+) displayed denser growth with glucose but no biofilm
formation, while a low level of aggregation was seen in the cultures of ED-negative OXC7218 regardless of glucose-supplementation. Pictures are representative
cultures from four independent growths. (B) The four ED-positive C. coli isolates (B13117, CV1257, Dg172, and Dg349) and the ED-negative C. coli strain OXC7218
were cultivated for 7 days at 37◦C under microaerobic conditions in glucose-free TSB with or without glucose supplementation. The bars show dry weight biomass
of 5 ml aliquots from cultures without glucose (white bars) and with glucose supplementation (black bars). The mean and standard deviations of four independent
cultures for each condition are shown. The statistical significance of the difference between the dry weight without glucose and with added glucose was evaluated
by Student’s t-test, as indicated by (∗∗∗p < 0.001) or NS (not significant). The arrows refer to the biofilm producing strains B13117 and Dg349 as in (A), which clearly
produce more biomass with glucose compared to the other non-biofilm producing strains tested.
agreement with the visually observed high biofilm production by
these isolates (Figure 6A, arrows).
Exometabolic Profiling of ED-Positive
Isolates Grown with and without Glucose
Campylobacter coli B13117 and CV1257 were subjected to
an exometabolomics “footprint” analysis to compare the
extracellular metabolic profiles of these ED-positive isolates
while growing in TSB with and without glucose. Changes in
the media composition after growth, reflecting the metabolic
activity of the bacteria (i.e., production and/or consumption of
metabolites and changes in growth substrates) were evaluated
using a validated method based on gas chromatography–
mass spectrometry (GC–MS) analysis of methyl chloroformate
derivatised samples (Smart et al., 2010) which primarily identifies
amino-acids and organic acids. In the principal component
analysis (PCA) shown in Figure 7A, it is clear that the footprints
of B13117 and CV1257 are highly similar when the isolates
are cultivated in TSB without glucose, as these samples group
closely together in the same region of the PCA plot (Figure 6A).
However, upon glucose supplementation, the samples from the
two isolates group in opposite quadrants of the plot (Figure 6A),
indicating a substantial but very dissimilar response to glucose.
A heat map, representing the relative concentrations of the
compounds detected by GC–MS, is shown in Figure 7B. The
largely similar extracellular metabolic profiles of B13117 and
CV1257, when cultivated in TSB without glucose, are clear
from the overall pattern seen in the heat map profile. After
growth with glucose a clear difference between the two isolates
in their responses in terms of metabolite concentrations was
observed (Figure 7B). Using known reference standards, some
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FIGURE 7 | Glucose dependent changes in extracellular metabolic profiles of B13117 and CV1257 isolates. (A) Principal components analysis (PCA) plots
of extracellular metabolites determined by gas chromatography–mass spectrometry (GC–MS). The PCA score plot is based on a data set consisting of three
independent replicates of C. coli B13117 and CV1257 cultivated in TSB with and without glucose for 24 h at 37◦C in a microaerobic atmosphere. However, only two
replicates of CV1257 without glucose were used due to contamination. For quality control, mixed pooled samples (labeled QC samples) were run alongside the
individual separate samples. (B) Heat map representation of the most abundant extracellular metabolites of C. coli B13117 and CV1257 samples used in (A). When
cultivated without glucose the two isolates display very similar metabolite profiles (two middle panels). Upon glucose supplementation both isolates display a distinct
shift in metabolic profile (two outer panels), but the two isolates respond very differently to glucose metabolism, which is seen by the highly different overall profile
patterns with glucose. Compounds that could be identified by comparison to standards are shown; most compounds that could be detected were not identified.
The colors represent the relative concentrations from high (white) to low (red).
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of these extracellular compounds could be identified. From
the results, it seems that glucose stimulates catabolism more
strongly in CV1257, since the extracellular concentration of
several metabolites both from and closely related to the citric-acid
cycle (e.g., succinate, pyruvate, oxaloacetate, lactate) was found to
increase when this strain was cultivated with glucose as compared
to a glucose-free medium, while the amino-acids isoleucine,
phenylalanine, and methionine decreased (Figure 7B). The
metabolic profile of B13117 also displayed a clear shift upon
cultivation with glucose, with certain amino-acids from the
growth medium again decreasing. However, far fewer glucose-
dependent extracellular metabolite alterations of B13117 were
identified with the GC–MS analysis, and in particular there was
little change in citric-acid cycle related organic acids (Figure 7B).
Given the strong tendency of the B13117 strain, but not CV1257,
to produce biofilm upon cultivation with glucose (Figure 6), the
distinct metabolic profile compared to CV1257 is consistent with
glucose carbon being preferentially directed into polysaccharide
formation in the former isolate.
Genomic Comparison of B13117 and
CV1257
In addition to metabolic differences in the B13117 and CV1257
isolates, we also searched for possible differences in gene
content that might be related to polysaccharide formation, in
particular in the capsule biosynthesis loci. A total of 1,996
unique coding sequences were identified between B13117 and
CV1257, 1,618 of which were present in both isolates. Among
the remaining coding sequences, 204 and 174 were specific to
B13117 and CV1257, respectively. Differences in the capsule
biosynthesis loci accounted for 35 (9.3%) of the isolate-specific
genes, with the region being approximately 5.6 kb longer in
B13117 (Supplementary Figure S3). Although the flanking genes
shared >90% sequence identity, the intervening sequences were
distinct (Supplementary Figure S3). Some of the additional
genes in this region in B13117 have predicted functions in
polysaccharide biosynthesis (Supplementary Table S3). With
respect to the remaining isolate-specific genes, 174 corresponded
to hypothetical proteins.
DISCUSSION
Glucose utilization by Campylobacter strains has only recently
been discovered, and it remains of uncertain physiological,
pathogenic and environmental significance. Taken together, the
results of this study illustrate that while the ED pathway is
indeed present in diverse isolates in the Campylobacter genus,
overall it is uncommon, as judged by the presence of the
complete glc locus in only 1.7% of over 6,000 genomes analyzed.
Importantly, we did not find a correlation between possession of
the key ED pathway genes and the ability to cause bloodstream
infections, which might have been expected given the abundance
of glucose in this niche. However, from our genome sequence
analyses, it is clear that the ED pathway is present in both
C. jejuni and C. coli isolates and we believe that this is the
first report of this pathway in C. jejuni subsp. jejuni. The
previous study of Vorwerk et al. (2015) employed a limited
number of human disease and pig C. coli isolates, while we
have shown that the glc locus is clearly conserved among C. coli
from more diverse sources. The majority of genomes in the
C. jejuni/coli PubMLST database were from human disease cases,
and, as humans typically become infected due to consumption
of contaminated animal products (Kaakoush et al., 2015), the
isolates analyzed effectively comprised an agricultural sample.
This raises questions about the advantages to C. coli of glucose
utilization in agricultural hosts. It is known that the glc locus
forms a plasticity region that can be transferred by natural
transformation between isolates (Vorwerk et al., 2015), so it
is likely that the region has been gained or lost repeatedly in
different isolates possibly in response to the differing availability
of glucose within distinct hosts or niches.
The genes comprising the glc locus were most variable among
genetically diverse C. jejuni isolates that were primarily not from
agricultural sources, but were from rats and wild birds and also
corresponded to C. jejuni subsp. doylei, the natural reservoir
of which remains unknown. Identification of clusters of closely
related C. jejuni from rats that shared identical ED types was
likely due to sampling: isolates with ED type 2 were recovered
primarily from two different farms over 18 months, while four of
the five isolates with ED type 3 were recovered from a third farm
over the same period (MacIntyre, in preparation). In contrast,
although C. coli isolates were also genetically diverse at the
wgMLST level, the glc locus was less variable in these isolates,
73% of which corresponded to ED type 1. This difference in
glc diversity between C. jejuni and C. coli may be related to
when the region was gained or lost with respect to the timing
of divergence of Campylobacter species/subspecies, or to host
differences, or to sparse sampling of C. coli from non-agricultural
sources. Whether this has any physiological consequences in
terms of overall pathway activity or specific enzyme activity will
require further investigation. There were also slight differences in
the gene contents of the glc locus, with wild bird isolates carrying
an additional ∼2700 bp downstream of glcP. Further work is
needed to understand the significance of this with respect to the
function of the pathway as a whole.
We have shown for the first time that individual glucose
metabolizing isolates can show distinct physiological responses
to the availability of this substrate, which suggests that glucose
can act as more than just an energy source for campylobacters.
What are the additional specific physiological advantages of the
possession of the ED pathway by a subset of Campylobacter
isolates? The production of NADPH by glucose-6-phosphate
dehydrogenase may be particularly significant, as this is not
only required for anabolic enzyme reactions, but also supplies
reductant for oxidative stress protection, mainly via the
thioredoxin system (Lu and Holmgren, 2014). In the oxygen-
sensitive microaerophilic campylobacters, this system (NADPH
+ thioredoxin reductase + thioredoxin) is crucial, as it supplies
electrons to the peroxiredoxins AhpC, Tpx and Bcp, each of
which has been shown to protect against oxidative stress by
removing damaging peroxides (Baillon et al., 1999; Atack et al.,
2008). Thioredoxin also reduces the cytoplasmic methionine
sulfoxide reductases MsrA and MsrB, which repair oxidized
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proteins (Atack and Kelly, 2008). Thus, ED-positive isolates may
be better able to cope with oxidative stress than ED-negative
isolates; this has been shown to be the case experimentally in
Pseudomonas putida (Chavarria et al., 2013) and in a range of
marine bacteria (Klingner et al., 2015). Secondly, the absence of
Pfk but the presence of the remaining EMP pathway enzymes
in campylobacters means that the ED reactions are not “linear.”
Instead, the metabolism of glucose in ED-positive isolates could
occur via the “cyclic” fusion of the ED and EMP reactions, as
has been shown in Pseudomonas spp., which interestingly also
lack Pfk (Nikel et al., 2015). As suggested for pseudomonads,
the physiological rationale for this might be related to an
enhanced hexose phosphate supply; this would be particularly
important for LOS, capsule and polysaccharide formation in
campylobacters.
In the BiologTM assays and liquid batch culture growth
experiments in minimal media, we confirmed that glucose
utilization and glucose-stimulated growth, respectively, occurred
in several ED-positive but not ED-negative isolates. This was
as expected and is in agreement with the findings of Vorwerk
et al. (2015). However, we found that addition of glucose to the
ED-positive isolates in rich, complex media, afforded a significant
stationary phase survival benefit, in terms of the maintenance of
viability over several days compared to the absence of glucose.
This effect is likely a product of the multiple functions of the ED
pathway in energy conservation, NADPH production and hexose
phosphate generation, which may allow better environmental
resilience. Moreover, in further physiological studies on glucose
utilization in rich complex media, we found some unexpected
differences between the ED-positive isolates with regard to
biofilm formation. It was clear from the dry weight measurements
and visual appearance of the cultures that glucose utilization
led to a massive increase in a pellicle or floating biofilm in
isolates like B13117 and Dg349 but not CV1257 and Dg172,
which suggested a fundamental difference in the way in which
glucose is being metabolized in these isolates. This conclusion
was supported by the metabolic profiling analysis we carried
out using GC–MS of broth culture supernatants, where we
could distinguish a distinct metabolic footprint when comparing
the high biofilm forming B13117 strain with the low biofilm
forming CV1257. In the latter strain only, several citric-acid
cycle organic acids and also lactate were increased in the culture
supernatants in a glucose dependent manner. Our conclusion is
therefore that the ED pathway in CV1257 primarily feeds glucose
into the primary metabolism of this strain. In contrast, B13117
may primarily utilize the ED encoded glucose kinase (Glk)
and possibly the EMP gluconeogenic reactions, for conversion
of glucose to glucose-6-phosphate and/or fructose-6-phosphate
which could be used for the production of surface structures such
as capsule or free polysaccharide. This would be consistent with
the observed massive increase in biofilm production by this strain
when cultivated with glucose.
Although, future analysis of gene expression patterns and
in vivo activities of ED and EMP pathway enzymes will
be required to explain the molecular basis for the different
metabolic responses to glucose in B13117 and CV1257, we found
differences in gene content in these isolates that might also
contribute to the differences in biofilm formation, with 378
isolate-specific coding sequences identified. We speculate that
some of these might be involved in polysaccharide synthesis
specifically related to biofilm formation. For example, the capsule
biosynthesis locus is ∼5.6 kB longer in B13117, and, although
the flanking regions are conserved, the intervening sequences
are distinct (Supplementary Figure S3). For example, there
are several distinct rbf genes in B13117: glucose-1-phosphate
cytidylyltransferase (rfbF), CDP-glucose 4,6-dehydratase (rfbG),
and CDP-abequose synthase (rbfJ), that encode enzymes of
polysaccharide synthesis, which might contribute to the observed
biofilm formation (Supplementary Table S3). The role of
these and other polysaccharide biosynthesis genes, biochemical
analysis of the biofilm polymer together with further detailed
analysis of gene function and regulation and enzyme activities
will elucidate the different phenotypes of these isolates seen
in the presence of glucose. It would also be informative to
determine how common the glucose stimulated survival and
biofilm phenotypes are by screening a much larger number of
isolates than was possible in this study.
Finally, there is overwhelming evidence showing that biofilm
production is of prime importance in many aspects of the
biology of Campylobacter isolates, particularly protection against
environmental stress (e.g., Svensson et al., 2009; Haddock et al.,
2010; Bae and Jeon, 2013; Pascoe et al., 2015) and that it is affected
by multiple external factors such as medium composition,
osmolarity and oxygen availability (Reeser et al., 2007; Reuter
et al., 2010). Host signals also play a role; a recent study showed
that C. jejuni 11168 can produce a glucan biofilm composed of
α-dextran as a specific response to the presence of host pancreatic
amylase (Jowiya et al., 2015). In contrast to the clear stimulatory
effect of glucose on biofilm formation we found here, the only
other sugar known to be metabolized by campylobacters, L-
fucose, was very recently shown to reduce biofilm formation in
the C. jejuni NCTC 11168 strain (Dwivedi et al., 2016). The
reduction was dependent on L-fucose transport and metabolism
and the authors speculated that L-fucose might be an intestinal
signal to maintain cells in a planktonic state. Taking our data
together with the findings of Dwivedi et al. (2016) it is now clear
that these two related hexose sugars are not only metabolized very
differently, but they also play very different roles in modulating
the crucial biofilm response of campylobacters.
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